AI helps IICT scientists spot promising drugs for Monkeypox, LSDV
Scientists at the IICT have utilized AI-driven computational tools to identify potential drug targets for monkeypox and Lumpy Skin Disease Virus. By using structural bioinformatics, the team identified 'lapatinib' as a promising candidate for repurposing as an antiviral.
Why it matters
This research demonstrates the efficiency of AI in accelerating drug discovery and repurposing, which is critical for responding to emerging zoonotic diseases.
Scientists at the CSIR-Indian Institute of Chemical Technology (IICT) have reported a significant advance in computational drug discovery, using artificial intelligence (AI) to identify potential therapies for poxvirus infections, including zoonotic infections like Lumpy Skin Disease Virus (LSDV) and monkeypox.
The article is a technical report on scientific research and contains no political or social bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in